Join Technosprout at industry conferences, technology forums, webinars,
and customer events
where we share insights, demonstrate solutions, and
discuss the future of enterprise
technology.
Meet our experts at upcoming events to explore the latest trends, discuss
your technology challenges, and discover practical solutions that drive measurable business
outcomes.
ETPharma’s 3rd Edition Pharma Tech Innovate Conclave, will explore how AI models are revolutionising drug design, predicting clinical...
An International Exhibition on Pharma & Healthcare Products, Medical Devices and Equipment, Pharmaceutical Machinery, Raw Materials, and Technologies...
India NBFC Summit & Awards 2026” with the theme “The Future of NBFC Unfolds” seeks to provide a physical platform for industry...
We are delighted to host the 14th edition of the India Wealth Management Forum, India’s premier gathering for senior private wealth management professionals...
India’s premier trading & fintech event returns for its 5th edition, stepping into the epicenter of online trading, fintech, and investment innovation...
India stands at the forefront of digital transformation in banking and finance, where rapid mobile adoption, progressive regulation, and digital-first consumers are reshaping...
No upcoming events in this category right now.
Instead of a sales conversation, expect practical insights focused on your business.
Some of
the conversations we typically have include:
Stay current with technology trends shaping modern enterprises.
Capital Market
On 17 September, the Securities and Exchange Board of India (SEBI) announced the expansion of the Samuhik Prativedan Manch, a technology-based common reporting mechanism, to Clearing Members who are also stock brokers, to reduce multiple compliance submissions.
Read article
Capital Market
The Securities and Exchange Board of India (Sebi) on Tuesday proposed shortening disaster recovery (DR) drills for market infrastructure institutions (MIIs) to at least four hours, while introducing tighter operational resilience and data recovery requirements for stock exchanges.
Read article
NBFC
Can AI fundamentally transform housing finance and accelerate lending? Pankaj Gadgil, MD & CEO of Aditya Birla Housing Finance, explains how AI and agentic solutions are improving productivity, underwriting and turnaround times.
Watch video
Pharma
The Maharashtra Food and Drug Administration (FDA) inspected as many as 2,902 drug manufacturing units across the state in the first seven months of this year and initiated action against 880 licensees for violations, the state government informed the legislative council on Monday.
Read article
Technology
India’s data centre industry sees a USD 700–800 billion investment opportunity as the government moves to resolve bottlenecks related to power, land, approvals and infrastructure, industry stakeholders said after a roundtable with Piyush Goyal.
Read article
Capital Market
Securities and Exchange Board of India (SEBI) is gearing up to implement new regulations for Artificial Intelligence (AI) usage in the securities market, including a 'kill switch' mechanism for emergency shutdowns. This move aims to balance innovation with market stability and investor protection in the rapidly evolving digital landscape.
Read article
Pharma
Tata Consultancy Services (TCS) has launched a new agentic AI platform specifically designed to streamline and accelerate the drug development lifecycle for pharmaceutical companies. The platform leverages advanced artificial intelligence and machine learning capabilities to enhance efficiency, improve decision-making, and ultimately speed up the delivery of new medicines to patients.
Read article
Pharma
Artificial intelligence holds immense potential to revolutionize clinical trials by making them more predictive and efficient. However, realising this potential hinges critically on addressing significant challenges related to data quality and integration, according to industry experts.
Read article
Capital Market
The Securities and Exchange Board of India (Sebi) on Monday launched the Incident Reporting Portal and Cyber Suraksha Portal to improve alerts and communication by market intermediaries regarding cybersecurity incidents.
Read article
Pharma
The U.S. Food and Drug Administration (FDA) has issued four observations for Dr. Reddy Laboratories Ltd.'s formulations facility in Visakhapatnam, Andhra Pradesh, according to the company's stock exchange filing.
Read article
Pharma
Prime Minister Narendra Modi stressed the need for at least one or two Indian pharmaceutical companies to be counted among the global top 5, urging stakeholders to work together to achieve this milestone.
Read article
Pharma
Ahmedabad: Gujarat has attracted fresh investment of Rs 2,500-Rs 3,000 crore in pharmaceutical manufacturing after the state Food and Drugs Control Administration (FDCA) approved 59 new allopathic drug-making plants in the 2025-26 financial year.
Read article
Pharma
The government has intensified its scrutiny of pharmaceutical quality, initiating approximately 950 actions against drug manufacturers since 2022, with over 1,100 cough syrup makers also currently undergoing intensive audits amid mounting quality concerns.
Read article
NBFC
The RBI has imposed tighter restrictions on the revolving credit facilities of NBFCs, aiming to curb excessive leveraging and promote financial stability.
Read article
Pharma
Continued momentum in formulations and a vaccine upswing helped Indian pharmaceutical exports touch $8 billion in the first quarter of the current fiscal year, with formulations accounting for the lion's share.
Read article
NBFC
RBI has simplified the methodology for identifying Non-Banking Financial Companies in the Upper Layer (NBFC-UL), making asset size of Rs 1 lakh crore and above the sole criterion for classification.
Read article
Pharma
Pharmaceutical companies are increasingly using Artificial Intelligence (AI) to unlock value from the vast amounts of fragmented data generated across the drug lifecycle—from early-stage R&D and clinical trials to manufacturing, quality control, supply chain and patient-support systems.
Read article
Pharma
"Indian pharma is moving beyond selective AI adoption, but the next phase will depend on trusted data, regulatory-ready systems and continued investments in digital capabilities," says Subhro Mallik, EVP and Global Head of Life Sciences, Infosys.
Read article
Pharma
Transparency must become more intelligent too. Publishing raw inspection counts can reward activity without showing consequence. A better public quality pulse would report repeat-finding rates, time to verified remediation, recurrence after closure, unresolved critical risks and sampling trends, with safeguards for lawful confidentiality and active enforcement.
Read article
Capital Market
Bank of Baroda's 1 TB of data, reportedly leaked on the Darknet, contained compromising information of as many as 2.7 million bank customers.
Read article
Capital Market
A separate legislation for artificial intelligence (AI) may soon be brought out, Union minister of state for electronics and IT Rajeev Chandrasekhar said on Wednesday as the government stepped up its crackdown on deepfakes.
Read article
Capital Market
From tech titans announcing massive investments in data centres and AI research to startups rolling out AI-powered innovations across sectors, India is witnessing an AI boom. The country’s...
Read article
Pharma
The latest list features several common medicines such as paracetamol, metformin combos (for diabetes), amoxicillin formulations (antibiotic), vitamin supplements, and cough syrups.
Read article
Capital Market
Shares of Central Depository Services (India) Ltd fell 4% in early trade on Friday after the Securities and Exchange Board of India (Sebi) imposed a penalty of ₹1 crore on CDSL for lapses in its IT infrastructure, which led to a data breach in 2022.
Read article
Pharma
Sun Pharmaceutical Industries Ltd will acquire Mumbai-based Innovcare Lifesciences Pvt Ltd for about $28.7 million (around Rs 271.2 crore) in an all-cash deal, as India's largest drugmaker.
Read article
Pharma
India’s pharmaceutical industry has earned its reputation as the “pharmacy of the world,” supplying roughly 40% of U.S. generic drugs, 60% of the global supply of vaccines and an estimated 25% of medicines used in the UK.
Read article
Pharma
Hyderabad: At a time when India’s pharmaceutical sector is cementing its position as the “pharmacy of the world,” the conversation is rapidly shifting from compliance-led manufacturing to intelligence-driven quality systems. This transition took center stage at the...
Read article
NBFC
RBI has simplified the methodology for identifying Non-Banking Financial Companies in the Upper Layer (NBFC-UL), making asset size of Rs 1 lakh crore and above the sole criterion for classification.
Read articleNo news articles in this category right now.
Whether you're attending an event, planning a technology initiative, or looking for expert
guidance,
we'd love to connect.
